NYSE Arca · CLDI
Calidi Biotherapeutics, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CLDI: Nov 12, 2026
Calidi Biotherapeutics, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-35.36.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · Quiver Quantitative- RTTNews · Sep 26, 12:18 PM EDTCalidi Put On Notice By NYSE For Non-Compliance In Stockholders' Equity; Shares Fall By 5%(RTTNews) – Calidi Biotherapeutics Inc. (CLDI), a biotechnology company, on Friday announced receiving a notice of non-compliance from the New York Stock Exchange (NYSE) American LLC regarding a deficiency in the company's stockholder equity. The notice was issued on September
- RTTNews · Sep 17, 10:30 AM EDTCalidi Biotherapeutics Unveils $1.2 Mln Offering Of Shares; Stock Up(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI), a biotechnology company developing targeted genetic medicines, announced that it has entered into a definitive stock purchase agreement with certain accredited investors and institutional buyers for the sale of 1.03 million shares
- RTTNews · Jul 21, 8:46 AM EDTCalidi Announces Reverse Stock Split; Shares Tumble 15% In Premarket Trading(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI), a biotechnology company, announced a proposed 1-for-16 reverse stock split of its outstanding common stock, effective July 31, 2026.
- RTTNews · Jun 24, 6:41 AM EDTCalidi Biotherapeutics Appoints Former Celgene Executive Corsee Sander To Board Of Directors(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI) announced the appointment of Corsee Sanders as an independent director on the company's Board of Directors, effective from June 17, 2026.
- RTTNews · Apr 29, 11:46 AM EDTCalidi Partners With TransferAI To Streamline IND Submission For Tumor Virotherapy CLD-401(RTTNews) – Calidi Biotherapeutics (CLDI), a biotechnology company, announced on Wednesday a partnership with TransferAI to drive efficiencies in the investigational new drug submission process for CLD-401, a tumour-targeting virotherapy.
- RTTNews · Apr 21, 10:04 AM EDTCalidi Releases New Data On RedTail Mechanism For Cancer Treatment(RTTNews) – Calidi Biotherapeutics Inc. (CLDI), a clinical-stage biotechnology company, released on Monday new data on the approach of simultaneous T-cell activation and expression of T-cell engagers in the tumor microenvironment at the 2026 annual meeting of the American Associa
- RTTNews · Mar 24, 9:21 AM EDTCalidi Partners With Avance Clinical For CLD-401 Trial Initiation In Australia; Stock Up(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI), a biotechnology company, on Tuesday announced a partnership with Avance Clinical, a contract research organisation (CRO) with experience in obtaining regulatory approvals and initiating clinical trials in Australia, to rapidly init
- RTTNews · Mar 10, 4:51 AM EDTCalidi Closes $6 Million Offering To Advance Cancer Immunotherapy Pipeline(RTTNews) – Calidi Biotherapeutics, Inc. (CLDI) announced the closing of a $6.0 million underwritten public offering, including the full exercise of the underwriter's over-allotment option.
- RTTNews · Mar 9, 1:43 AM EDTCalidi Biotherapeutics Prices $5.2 Mln Public Offering Of Shares And Warrants(RTTNews) – Calidi Biotherapeutics, Inc.(CLDI), a biotechnology firm, announced the pricing of its underwritten public offering of 10.52 million units at a price of $0.50 per unit. Each unit has one share of common stock or a pre-funded warrant.
- RTTNews · Mar 5, 8:27 PM ESTCalidi Sinks On Proposed Public Offering; Shares Hit New 52-Week Low(RTTNews) – Shares of Calidi Biotherapeutics (CLDI) fell nearly 31% overnight after the company announced a proposed underwritten public offering of units consisting of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants. Each share o
- The Motley Fool · Aug 8, 4:45 PM EDTCalidi Loss Down 23 Percent in Fiscal Q2GAAP earnings per share of $(1.99) for Q2 2025 missed analyst estimates by $0.07.
- Quiver Quantitative · Jul 22, 8:14 AM EDTCalidi Biotherapeutics Invites Investors to Webinar on Precision Genetic Medicine AdvancesCalidi Biotherapeutics invites investors to a webinar discussing its targeted therapies and proprietary RedTail™ platform on July 24, 2025.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Calidi Biotherapeutics, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.